The National Heart, Lung, and Blood Institute (NHLBI) will hold a press
conference on Thursday, September 18, 1997, at 10:00 a.m. to announce
the results of an important clinical trial involving the prevention of
strokes in children with sickle cell anemia.
The NHLBI is also issuing a clinical alert to U.S. physicians who treat
children with sickle cell anemia.
The press conference will be held in the Franklin Square Room at the
Grand Hyatt, Washington, 1000 H Street, N.W., Washington, D.C. 20001.
It is being held in conjunction with a major national conference on
sickle cell disease, commemorating the 50th Anniversary of the NHLBI
and the 25th Anniversary of its Sickle Cell Disease Program. The
conference is scheduled for Thursday, September 18th, through Saturday,
September 20th, at the Grand Hyatt, Washington.
Conference speakers include: Dr. Francis S. Collins, Director, National
Institute for Human Genome Research, NIH; Dr. Marilyn H. Gaston, Assistant
Surgeon General and Director, Bureau of Primary Care, DHHS; NHLBI Director
Dr. Claude Lenfant; Dr. Ronald Nagel, Professor of Medicine, Albert
Einstein University, NY; Dr. David Nathan, President, Dana Farber Cancer
Center, Boston; Dr. Arthur Neinhuis, President, St. Jude's Hospital,
Memphis; Dr. David Satcher, Director, Centers for Disease Control and
Prevention; Dr. George Stamapoyannopoulos, Professor of Medicine, University
of Seattle; and Dr. Louis Sullivan, President, Morehouse Medical College, Atlanta.
For a copy of the conference program, call the NHLBI SCD Program at (301) 435-0055.